Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus

Condition:   Type 1 Diabetes Intervention:   Drug: Semaglutide weekly injection Sponsor:   Ministry of Health, Saudi Arabia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials